Duraphen
WikiDoc Resources for Duraphen |
Articles |
---|
Most recent articles on Duraphen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Duraphen at Clinical Trials.gov Clinical Trials on Duraphen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Duraphen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Duraphen Risk calculators and risk factors for Duraphen
|
Healthcare Provider Resources |
Causes & Risk Factors for Duraphen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Duraphen is a combination drug, containing Guaifenesin (an expectorant), which helps loosen chest congestion, making coughs more productive, and Phenylephrine (a decongestant), that shrinks blood vessels in the nose, improving symptoms of nasal congestion. This combination of drugs is used primarily to treat allergic rhinitis, and chest congestion caused by allergies, the common cold or flu.